Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT2i in Adolescents With Persistent Albuminuria
NCT07405216Phase 4Recruiting
- Sponsor
- Centenario Hospital Miguel Hidalgo
- Start
- Apr 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in chronic kidney disease (CKD), albuminuria, sponsored by Centenario Hospital Miguel Hidalgo. Started Apr 2026; status: recruiting.
02
Drugs
dapagliflozin
03
Conditions
chronic kidney disease (CKD)albuminuria
Beyond the preview
Go deeper on NCT07405216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07405216.